BACH1 and cancer: As our pan-cancer analysis revealed the overexpression of the BACH1 antigen in a variety of tumors with preferential lymphatic metastasis but not in most of tumors with preferential hematogenous metastasis, we propose that anti-BACH1 autoantibodies might be general markers for lymph node metastasis, even in other tumors with preferential lymphatic metastasis.